Skip to content Skip to search Skip to footer
Washington University in St. Louis

Institute for Public Health

Menu
  • About
    • Our Team
    • Contact & Location
    • National Council
    • Employment Opportunities
  • Centers
    • Center for Community Health Partnership & Research
    • Center for Dissemination & Implementation
    • Center for Health Economics & Policy
    • Center for Human Rights, Gender & Migration
    • Global Health Center
    • Harvey A. Friedman Center for Aging
    • Public Health Data & Training Center
  • Programs
    • Faculty Scholar Program
    • Summer Research Program
    • Gun Violence Initiative
    • Life Outside of Violence (LOV)
    • Human Trafficking Collaborative Network
    • Africa Initiative
  • News & Blog
    • News
    • Blog
    • Newsletter Sign-up
  • Events
    • Annual Conference
    • Calendar
    • Event Series
  • Developing Leaders
    • Undergraduate
    • Graduate
    • Postgraduate
  • Resources
    • Funding Opportunities
    • Public Health Careers
    • Research Centers
    • Grant Resource Language
  • Give

Tag: Rachel Sachs

Medicare chief vows to implement drug pricing reforms on time (Links to an external site)

August 16, 2022August 18, 2022

Institute Faculty Scholar and Treiman Professor of Law, Rachel Sachs JD, MPH, discusses the recent Inflation Reduction Act that will ultimately enable Medicare to negotiate drug prices with the pharmaceutical industry.

Since Biden took over, Big Pharma has spent $205 million to protect drug price status quo, analysis finds (Links to an external site)

August 16, 2022August 18, 2022

Rachel Sachs JD, MPH, institute Faculty Scholar and Treiman Professor of Law at the School of Law, speaks with Fierce Pharma about the pharmaceutical industry’s response to the Biden administration, specifically the recent Inflation Reduction Act.

How Medicare drug costs could change under the Inflation Reduction Act (Links to an external site)

August 15, 2022August 18, 2022

Institute Faculty Scholar and Treiman Professor of Law, Rachel Sachs JD, MPH, discusses the impact of a new bill that allows Medicare to negotiate drug prices for a select number of expensive drugs.

HEALTH CARE BRIEFING: Drug Bill Shows Limits of Democrat’s Power (Links to an external site)

August 10, 2022August 11, 2022

Rachel Sachs JD, MPH, institute faculty scholar and Treiman Professor of Law at the School of Law, discusses recent federal legislation that enables Medicare to negotiate the prices of some of the most expensive pharmaceuticals

Major drug price reforms head for Biden’s signature as PhRMA weighs legal options (Links to an external site)

August 10, 2022August 11, 2022

Institute Faculty Scholar and Treiman Professor of Law at the School of Law, Rachel Sachs JD, MPH, discusses with EndpointNews possible legal avenues for PhRMA following recent federal legislation

Dems’ Medicare win faces long, uncertain future (Links to an external site)

August 9, 2022August 9, 2022

Institute Faculty Scholar and Treiman Professor of Law, Rachel Sachs discusses the new bill that would allow Medicare to negotiate drug prices for a select number of expensive drugs.

Drug industry on verge of rare defeat (Links to an external site)

August 6, 2022August 9, 2022

Institute Faculty Scholar and Treiman Professor of Law, Rachel Sachs discusses the new bill that would allow Medicare to negotiate drug prices for a select number of expensive drugs

Drug industry poised for rare political loss on prices (Links to an external site)

July 28, 2022August 8, 2022

Institute Faculty Scholar and Treiman Professor of Law, Rachel Sachs discusses the new Senate bill that would allow Medicare to negotiate drug prices for a select number of very expensive drugs in this Washington Post article.

Ad Targeting Manchin and AARP Mischaracterizes Medicare Drug-Price Negotiations (Links to an external site)

July 25, 2022July 31, 2022

Institute Faculty Scholar and Treiman Professor of Law, Rachel Sachs, weighs in on the validity of an ad targeting Senator Joe Manchin and AARP, characterizing it as “fairly misleading”

People with chronic illness in US now having medication restricted (Links to an external site)

July 7, 2022July 15, 2022

Rachel Sachs, institute faculty scholar and Treiman Professor of Law at the School of Law, discusses with Bloomberg the potential for restrictions on medications in Missouri following the Supreme Court’s overturning of Roe v. Wade.

Institute for Public Health

Sign up for our newsletter

Contact us

  • Facebook
  • Twitter

More ways to connect

HTML Hyperlinks

Visit us on Vimeo

Subscribe to us on Medium

©2022 Washington University in St. Louis